Budget vs premium
SnagRx vs Start Willow: Which Costs Less Over 12 Months? (2026)
SnagRx or Start Willow? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
If SnagRx and Start Willow are the two tabs still open, the deciding information is not on either homepage — it is in what happens after the first month.
On the number that matters after the first month, they are not close: SnagRx runs $99/mo against $299/mo at Start Willow — 3.0x more, every month, for the same drug class.
The comparison below starts from published pricing, converts it into annual cost, and then asks what the more expensive side is delivering for the difference. Where a provider quotes only after intake, that is recorded as the answer rather than replaced with a guess.
The short answer
- Lowest 12-month cost
- SnagRx — $828 against $3,538 at Start Willow, on each provider's own best published pricing.
- Most predictable bill
- SnagRx — Flat rate at every dose, so titration does not change what you are charged.
- Fastest route to a first shipment
- SnagRx — 5-minute intake, clinician review typically within 5 hours and always within 24, then free next-day UPS or FedEx in temperature-controlled packaging.
- Easiest to pay for
- SnagRx — Neither publishes financing; both expect the full amount monthly.
The short version: SnagRx vs Start Willow
The rows below are the ones that differ enough between these two to be worth your attention.
| SnagRx | Start Willow | |
|---|---|---|
| Advertised price | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan | From $249 the first month, then $299/mo |
| Rate after promotions | $99/mo | $299/mo |
| Pricing structure | Flat rate at every dose | Promotional first month, then standard rate |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Payment options | Card only, no financing published | Card only, no financing published |
| Membership fee | None | None |
| How fast you start | 5-minute intake, clinician review typically within 5 hours and always within 24 | Fully online, no in-person visits |
| State coverage | 48 states | Not published |
| Patient reviews | 9,860 | 6,385 |
| eRxDoctor score | 7.5/10 | 7.0/10 |
SnagRx vs Start Willow on total cost, not entry price
Comparing entry prices across these two would be actively misleading, because they escalate differently. So the table works in the timeframe treatment actually happens in.
| SnagRx | Start Willow | |
|---|---|---|
| First month | $99 | $249 |
| Months 2 onward | $99/mo | $299/mo |
| 6-month total | $594 | $1,744 |
| 12-month total | $1,188 | $3,538 |
| Best published plan | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr | No multi-month discount published |
The twelve-month spread is $2,710. That is the number to hold Start Willow against: it has to justify roughly $226 extra every month.
Price escalation to plan for: Start Willow moves from $249 to $299, a 20% increase. Set a calendar reminder for the month it changes.
Is Start Willow worth the premium?
Before treating the cheaper option as the obvious one, it is worth naming what the more expensive one includes — at Start Willow that is direct-pay model that bypasses insurance pre-authorization, plus delivery guaranteed in 3 days or less.
SnagRx counters with the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly, and the thing it asks you to accept in return: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
Price gaps in this market rarely reflect a different molecule; they reflect a different amount of human contact. Decide how much of that you actually intend to use before paying for it.
SnagRx: what you are buying
The pitch is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly. SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping.
Practically: 5-minute intake, clinician review typically within 5 hours and always within 24, free next-day UPS or FedEx in temperature-controlled packaging, and a pricing model that is flat rate at every dose.
On the clinical side, 1:1 nursing staff plus a secure patient portal for refills and dose changes, prescribing compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Clinician review typically within 5 hours; next-day temperature-controlled shipping
- Full refund if the prescription is declined, plus a 6-month weight-loss guarantee (terms apply)
- Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
- Price locked flat at every dose and at renewal — no re-pricing during titration
SnagRx cons
- Clinician network covers 48 states, not all 50
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
- The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
Against Start Willow specifically, the trade you are making: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
A closer look at Start Willow
From $249 per Month
From signup to first shipment: fully online, no in-person visits, then delivery guaranteed in 3 days or less. Billing follows a promotional first month, then standard rate structure.
Behind the prescription sits direct-pay model that bypasses insurance pre-authorization. Available medication: compounded semaglutide and compounded tirzepatide.
Start Willow pros
- Medications comparable to Ozempic and tirzepatide
- No insurance needed and no membership fees
- Direct-pay model bypasses insurance pre-authorization entirely
- Delivery guaranteed in 3 days or less
Start Willow cons
- Price rises from $249 first month to $299/month ongoing
- Ongoing $299/month is among the higher rates on this list
- Compounded medication only, no branded Ozempic or Wegovy
The cost of choosing this over SnagRx: at $299 ongoing it is among the most expensive compounded programs here.
Picking between them
Choose SnagRx if:
- delivery works the way you want it to: free next-day UPS or FedEx in temperature-controlled packaging
- you want to start on their timeline: 5-minute intake, clinician review typically within 5 hours and always within 24
- the level of clinical contact suits you: 1:1 nursing staff plus a secure patient portal for refills and dose changes
- the feature you would actually use: the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly
Choose Start Willow if:
- the level of clinical contact suits you: direct-pay model that bypasses insurance pre-authorization
- what it leads on is worth paying for in your case: a delivery guarantee of three days or less and no membership stacked on the medication price
- delivery works the way you want it to: delivery guaranteed in 3 days or less
- you want to start on their timeline: fully online, no in-person visits
The trade-offs, stated plainly
On price. $99/mo against $299/mo. Start Willow is asking you to pay for a delivery guarantee of three days or less and no membership stacked on the medication price; decide whether that is a line item you will use.
On commitment. SnagRx rewards a longer commitment (12-month semaglutide plan at $69/mo ($828 a year)), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. The support models differ — 1:1 nursing staff plus a secure patient portal for refills and dose changes against direct-pay model that bypasses insurance pre-authorization — and that difference is felt in week two, not week one.
On medication. SnagRx covers compounded semaglutide and compounded tirzepatide; Start Willow covers compounded semaglutide and compounded tirzepatide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
The clinical evidence, separated from the marketing
Before either program's marketing claims, the underlying evidence — which belongs to the medication, not the platform.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
SnagRx vs Start Willow: common questions
What happens when Start Willow's promotional price ends?
The rate moves to $299/mo, a 20% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Which is cheaper to start, SnagRx or Start Willow?
SnagRx, at $99 against $249. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
Which has more patient reviews, SnagRx or Start Willow?
SnagRx, with 9,860 against 6,385. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do SnagRx or Start Willow take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Are SnagRx and Start Willow legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. SnagRx operates on flat rate at every dose with pricing published upfront, Start Willow on promotional first month, then standard rate, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
The verdict
SnagRx is the cheaper year by $2,710, and for a straightforward course of treatment that settles it.
Start Willow earns the difference in one situation: when a delivery guarantee of three days or less and no membership stacked on the medication price is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- Directmeds vs SnagRxPublished price vs quote-only
- Enhance MD vs SnagRxBudget vs premium
- Mochi Health vs Start WillowBudget vs premium
- Elevate Health vs Start WillowBudget vs premium
- TrimRx vs GalaBudget vs premium
- TrimRx vs Enhance MDBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by SnagRx or Start Willow, and does not sell treatment. Read our ranking methodology.